Influenza and COVID-19 Vaccination in Children Receiving Long-Term Ventilation
Robert J. Graham,Luis F. Enriquez,Angelo F. Elmi,James V. Zavadoski,Lisa G. Bielak,Christopher D. Baker,Jonathan M. Mansbach
DOI: https://doi.org/10.1001/jamanetworkopen.2024.30989
2024-08-31
JAMA Network Open
Abstract:Children who receive tracheostomy and home ventilation (HV) are at high risk of acute respiratory infections (ARIs), the leading cause of hospitalization and death among these patients. 1 The Centers for Disease Control and Prevention and the American Academy of Pediatrics recommend annual influenza and COVID-19 vaccinations for all children aged 6 months or older, unless medically contraindicated. 2 ,3 Concern, however, exists that growing antivaccination sentiments, emerging "medical freedom movements," and specific mistrust of COVID-19 vaccines 4 may negatively affect rates of vaccination among children at high risk. Given these concerns, we examined rates of influenza and COVID-19 vaccination among children receiving long-term HV. We hypothesized that uptake of the influenza vaccine would be higher than COVID-19. 5 From March 2022, to October 2023, the 13-center (12 states and the District of Columbia) Multicenter Tracheostomy Collaboration (MyTRaCh) study enrolled 193 children receiving transtracheal HV into a prospective cohort study and collected longitudinal tracheal aspirates to examine the pathobiology of ARIs. The Boston Children's Hospital institutional review board approved this study. Twelve collaborating sites had reliance and data-use agreements. We excluded children with cystic fibrosis, immunodeficiencies, and primary ciliary dyskinesia; those living in long-term care facilities; and, for this analysis, those ineligible for vaccination based on age at enrollment. Site teams collected demographics, race and ethnicity data, medical history, and immunization data by structured caregiver interview and reconciliation with available records. Race and ethnicity were extracted from chart review and self-identified during parent-reported screening. Race and ethnicity were collected to better describe the cohort and as part of the analysis plan in compliance with National Institutes of Health/National Institute of Allergy and Infectious Diseases requirements for the larger microbiome study. We conducted descriptive statistics and multivariable logistic regression using generalized estimating equations to account for clustering by center to analyze the association between demographics and vaccination status (eMethods in Supplement 1). Findings were reported in accordance with the STROBE reporting guideline. The significance threshold was P < .05 using a 2-sided test. All data management and analysis were conducted using SAS, version 9.4. Of 313 participants, we confirmed complete data for 282 (90%), and 193 (62%) were age eligible for vaccination. The median age was 10.51 years (IQR, 6.26-14.1 years) with a median age of tracheostomy of 6.0 months (IQR, 2.8-48 months). Sixty-three percent were male, and 58% were non-Hispanic White. A total of 145 (75%) received the influenza vaccine either annually or most years. A total of 102 (53%) completed their initial COVID-19 vaccine series; however, only 45 participants (23%) received the recommended booster. Among children who received an influenza vaccine, 96 (61%) also received a COVID-19 vaccine; the decreasing frequency of COVID-19 vaccination corresponded with that of the influenza vaccine. Among 35 participants (18%) who never received an influenza vaccine, 6 (17%) received a COVID-19 vaccine (Table 1). Our multivariable analysis adjusting for demographics and clustering by site found that those with significantly higher odds of receiving any COVID-19 vaccine were older (odds ratio [OR], 1.14; 95% CI, 1.09-1.19) and had a previous influenza vaccine (OR, 8.93; 95% CI, 4.59-17.37) (Table 2). Children with tracheostomy and HV are at high risk of morbidity and mortality from viral ARIs. Among MyTRaCh enrollees, we found significant discrepancy between influenza and COVID-19 vaccination status. Compared with immunization status overall among US children aged younger than 18 years, our cohort had higher adherence to influenza vaccination (75% vs 50%), similar rates of initial COVID-19 vaccination (53% vs 50%), and much lower rates of receiving a COVID-19 booster (23% vs 50%). 5 ,6 MyTRaCh families have successfully integrated complex technology support (eg, tracheostomy tubes, home ventilators, gastrostomy tubes, time-consuming medical care regimens) into their lives and understand their children's vulnerabilities. Their engagement with tertiary care centers (ie, HV programs), primary care, and home care nursing suggests that opportunities for screening, education, and access were not barriers to vaccination. Unfortunately, the low vaccination rates in this study population suggest that COVID-19 vaccine hesitancy is apparent for adults making decisions for this very high-risk group of children. 5 This study's limitations included (1) reliance on parental reporting as the primary data source, although caregivers may overe -Abstract Truncated-
medicine, general & internal